Ysios Capital Partners target the entire healthcare and biotechnology industry with special focus on pharmaceuticals, diagnostics and medical devices.

Ysios's investment strategy allows for investments in early stage companies looking for first round funding through to later-stage or pharmaceutical spin-off companies. Our investments target companies focusing on product development in the biotechnology, emerging pharmaceuticals, healthcare and medical technology sectors.